Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method

Clinical Pharmacology and Therapeutics

Volumn 80, Issue 2, 2006, Pages 146-158

  Ndovi, Themba T ^a   Choi, Leena ^a   Caffo, Brian ^a   Parsons, Teresa ^a   Baker, Sharon ^a   Zhao, Ming ^a   Rohde, Charles ^a   Hendrix, Craig W ^a  

^a SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLOROQUINE; FRUCTOSE; PROSTATE SPECIFIC ANTIGEN; SALICYLIC ACID;

ANALYTIC METHOD; ARTICLE; BAYES THEOREM; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FRACTIONATION; GEOMETRY; HUMAN; MALE; MASTURBATION; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE FLUID; QUANTITATIVE ANALYSIS; SEMEN ANALYSIS; SEMINAL VESICLE;

ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMALARIALS; ASPIRIN; BAYES THEOREM; BIOLOGICAL MARKERS; CHLOROQUINE; FRUCTOSE; HUMANS; HYDROGEN-ION CONCENTRATION; LINEAR MODELS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; QUALITY CONTROL; REGRESSION ANALYSIS; SEMEN; SEMINAL VESICLES;

EID: 33746689127     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2006.04.013     Document Type: Article

References (41)

1. Taylor S., Boffito M., and Vernazza P.L. Antiretroviral therapy to reduce the sexual transmission of HIV. J HIV Ther 8 (2003) 55-66
2. Eliasson R., Malmborg A.S., Dornbusch K., and Kvist U. Secretion of erythromycin into human semen-methodological, experimental and clinical aspects. Curr Med Res Opin 5 Suppl 2 (1978) 31-33
3. Dalhoff A., and Weidner W. Diffusion of ciprofloxacin into prostatic fluid. Eur J Clin Microbiol Infect Dis 7 (1988) 438-439
4. Rui H., Mevag B., and Purvis K. Two-dimensional electrophoresis of proteins in various fractions of the human split ejaculate. Int J Androl 7 (1984) 509-520
5. Tauber P.F., Zaneveld L.J., Propping D., and Schumacher G.F. Components of human split ejaculates. II. Enzymes and proteinase inhibitors. J Reprod Fertil 46 (1976) 165-171
6. Naber K.G., Kinzig M., Adam D., Sorgel F., Bajorski A.H., and Kiehn R. Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue. Infection 19 (1991) 30-35
7. Naber K.G., Sorgel F., Kinzig M., and Weigel D.M. Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. J Urol 150 Pt 2 (1993) 1718-1721
8. Jarow J.P. Seminal vesicle aspiration of fertile men. [see comments]. J Urol 156 (1996) 1005-1007
9. Lundquist F. Aspects of the biochemistry of human semen. Acta Physiol Scand 19 (1949) 1-95
10. Lindholmer C., Carlstrom A., and Eliasson R. Occurrence and origin of proteins in human seminal plasma with special reference to albumin. Andrologia 6 (1974) 181-196
11. Eliasson R., and Malmborg A.S. Concentrations of doxycycline in human seminal plasma. Scand J Infect Dis Suppl (1976) 32-36
12. Naber K.G., Sorgel F., Kees F., Jaehde U., and Schumacher H. Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration. Am J Med 87 (1989) 57S-59S
13. Rui H., Torjesen P.A., Jacobsen H., and Purvis K. Testicular and glandular contributions to the prolactin pool in human semen. Arch Androl 15 (1985) 129-136
14. Schramm P. Ofloxacin. concentration in human ejaculate and influence on sperm motility. Infection 14 Suppl 4 (1986) S274-S275
15. Comhaire F. Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection. J Urol 138 (1987) 828-830
16. van Praag R.M., Repping S., de Vries J.W., Lange J.M., Hoetelmans R.M., and Prins J.M. Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma. Antimicrob Agents Chemother 45 (2001) 2902-2907
17. Ndovi T.T. Compartmental kinetics of antiretroviral drugs in the human male genital tract (2005), Graduate Training Program in Clinical Investigation, Johns Hopkins University, Baltimore [doctoral thesis]
18. Ndovi TT, Parsons T, Choi L, Caffo B, Rohde C, Hendrix CW. A new method to quantitatively estimate seminal vesicle and prostate gland contributions to ejaculate. Br J Clin Pharmacol. In press 2006.
19. Beuter H.O. Methods of enzymatic analysis. 3rd ed. Vol 6. (1985), VCH, Weinheim Germany
20. Laffin R.J., Chan D.W., Tanasijevic M.J., Fischer G.A., Markus W., Miller J., et al. Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system. a multicenter evaluation of analytical performance. Clin Chem 47 (2001) 129-132
21. Fuller W.A. Measurement error models (1987), Wiley, New York
22. Winsor C.P. Which regression?. Biometrics 2 (1946) 101-109
23. Choi L. Modeling biomedical data and the foundations of bioequivalence [doctoral thesis] (2005), Department of Biostatistics, Johns Hopkins University, Baltimore
24. Kershaw R.A., Mays D.C., Bianchine J.R., and Gerber N. Disposition of aspirin and its metabolites in the semen of man. J Clin Pharmacol 27 (1987) 304-309
25. Wolff H., and Anderson D.J. Potential human immunodeficiency virus-host cells in human semen. [letter]. AIDS Res Hum Retroviruses 4 (1988) 1-2
26. Tauber P.F., Zaneveld L.J., Propping D., and Schumacher G.F. Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. J Reprod Fertil 43 (1975) 249-267
27. Owen D.H., and Katz D.F. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J Androl 26 (2005) 459-469
28. Meacham R. From Androlog. J Androl 23 (2002) 330-331
29. Shedlovsky L., Belcher D., and Levenstein I. Titrations of human seminal fluid with acids and alkalis and their effects on the survival of sperm motility. Am J Physiol 136 (1942) 535-541
30. Makler A., David R., Blumenfeld Z., and Better O.S. Factors affecting sperm motility. VII. Sperm viability as affected by change of pH and osmolarity of semen and urine specimens. Fertil Steril 36 (1981) 507-511
31. Wolters-Everhardt E., Dony J.M., Lemmens W.A., Doesburg W.H., and De Pont J.J. Buffering capacity of human semen. Fertil Steril 46 (1986) 114-119
32. Pfau A., Perlberg S., and Shapira A. The pH of the prostatic fluid in health and disease. implications of treatment in chronic bacterial prostatitis. J Urol 119 (1978) 384-387
33. Beja O., and Bibi E. Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli. Proc Natl Acad Sci U S A 93 (1996) 5969-5974
34. Vezmar M., and Georges E. Direct binding of chloroquine to the multidrug resistance protein (MRP). Possible role for MRP in chloroquine drug transport and resistance in tumor cells. Biochem Pharmacol 56 (1998) 733-742
35. Reece M., Prawitt D., Landers J., Kast C., Gros P., Housman D., et al. Functional characterization of ORCTL2-an organic cation transporter expressed in the renal proximal tubules. FEBS Lett 433 (1998) 245-250
36. Khamdang S., Takeda M., Noshiro R., Narikawa S., Enomoto A., Anzai N., et al. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 303 (2002) 534-539
37. Lizana J., Eneroth P., Bystrom B., and Bygdeman M. Studies on the constancy of transudated and locally produced proteins in human seminal plasma. Int J Fertil 32 (1987) 71-76
38. Poland D.C., Kratz E., Vermeiden J.P., De Groot S.M., Bruyneel B., De Vries T., et al. High level of alpha1-acid glycoprotein in human seminal plasma is associated with high branching and expression of Lewis(a) groups on its glycans. supporting evidence for a prostatic origin. Prostate 52 (2002) 34-42
39. Janssen P.L., Hollman P.C., Reichman E., Venema D.P., van Staveren W.A., and Katan M.B. Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low. Am J Clin Nutr 64 (1996) 743-747
40. Gustafsson L.L., Walker O., Alvan G., Beermann B., Estevez F., Gleisner L., et al. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15 (1983) 471-479
41. Naber K.G., Sorgel F., Kees F., Schumacher H., Metz R., and Grobecker H. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue. J Antimicrob Chemother 22 Suppl D (1988) 199-207